Koen Andries
Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug, now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis.Career
Andries graduated as a Veterinarian and obtained a PhD at the University of Ghent in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in Beerse until 2004. In 2004 he continued his research at Tibotec in Mechelen.Recognition
